Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: ER+Neoadjuvant -Breast-Oestrogen receptor positive breast cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I